{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 461935346
| IUPAC_name = 1-''N''-(2,3-dihydroxypropyl)-5-[''N''-(2,3-dihydroxypropyl)acetamido]-3-''N''-(2-hydroxyethyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
| image = Ioxilan structure.png
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|ioxilan}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = B<!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = Rx-only <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = [[intravenously]]
<!--Pharmacokinetic data-->
| bioavailability = N/A
| protein_bound = negligible
| metabolism =  
| elimination_half-life = 2 hours
| excretion = Mostly [[renal]]
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 107793-72-6
| ATC_prefix = V08
| ATC_suffix = AB12
| PubChem = 3743
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3612
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = A4YJ7J11TG
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02161
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201075
<!--Chemical data-->
| C=18 | H=24 | I=3 | N=3 | O=8
| molecular_weight = 791.112
| smiles = O=C(N(c1c(I)c(c(I)c(c1I)C(=O)NCCO)C(=O)NCC(O)CO)CC(O)CO)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C18H24I3N3O8/c1-8(28)24(5-10(30)7-27)16-14(20)11(17(31)22-2-3-25)13(19)12(15(16)21)18(32)23-4-9(29)6-26/h9-10,25-27,29-30H,2-7H2,1H3,(H,22,31)(H,23,32)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UUMLTINZBQPNGF-UHFFFAOYSA-N
}}

'''Ioxilan''' is a diagnostic [[contrast agent]].  It is injected [[intravenously]] before taking [[X-ray]] images to increase [[artery|arterial]] contrast in the final image.  It is marketed under the trade name '''Oxilan''' by [[Guerbet]], L.L.C.

{{Contrast media}}

[[Category:Radiocontrast agents]]
[[Category:Iodoarenes]]
[[Category:Acetanilides]]
[[Category:Polyols]]


{{Pharm-stub}}